Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Effect of methylphenidate treatment as an intervention for children diagnosed with ASD showing ADHD symptoms: Systematic Review
Jönköping University, School of Education and Communication, HLK, CHILD.
2023 (English)Independent thesis Advanced level (degree of Master (One Year)), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

Autism Spectrum Disorder (ASD), previously known as Pervasive Development Disorder (PDD) is a developmental disorder present from early childhood. Children diagnosed with ASD commonly exhibit symptoms of ADHD resulting in increased severity of symptoms and impairment of functioning. This group of children is frequently treated with methylphenidate which has been recommended by some but criticised by others. This systematic review aims to explore the effect of methylphenidate treatment on symptoms of ASD, functioning and adverse effects  Six articles were extracted from five different databases (Medline, Psych INFO, PubMed, Scopus, and Web of Science) and chosen based on a pre-determined inclusion and exclusion criteria. The results show that MPH treatment may be successful as an intervention for some children with ASD showing ADHD symptoms while other children are very susceptible to adverse effects with some being unable to tolerate the treatment. The chosen studies provided limited acknowledgement of the effect on functioning making it an important focus for future research. It is important that professionals are aware of the negative effects MPH might cause to ensure a positive outcome and well-being for children with this disorder. There is a need for further understanding of the connection between ASD and ADHD with additional exploration of possible moderators such as IQ, dose size and level of functioning.  

Place, publisher, year, edition, pages
2023. , p. 33
Keywords [en]
Children, Autism Spectrum Disorder (ASD), Methylphenidate (MPH), Attention-deficit/Hyperactivity Disorder (ADHD), adverse effects, functioning
National Category
Psychiatry Pharmacology and Toxicology Other Health Sciences Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:hj:diva-62024ISRN: JU-HLK-SBU-2-20230160OAI: oai:DiVA.org:hj-62024DiVA, id: diva2:1782864
Subject / course
HLK, Child Studies
Supervisors
Examiners
Available from: 2023-08-28 Created: 2023-07-17 Last updated: 2025-02-20Bibliographically approved

Open Access in DiVA

fulltext(768 kB)356 downloads
File information
File name FULLTEXT01.pdfFile size 768 kBChecksum SHA-512
88d67977c2706df1a6153ed2adc2dd0a14f2297aefb21528cc00e8f5bb0ee54a76136132783d671430acc699d7d9ccd9d38b1db206dc7d6d27ddff457340c1ae
Type fulltextMimetype application/pdf

By organisation
HLK, CHILD
PsychiatryPharmacology and ToxicologyOther Health SciencesPublic Health, Global Health and Social Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 359 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 739 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf